Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
María Infantino, Massimo Pieri, Marzia Nuccetelli, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108095-108095
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Matthijs Oyaert, Marie‐Angélique De Scheerder, Sophie Van Herrewege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Mariapia Guerrieri, Beatrice Francavilla, Denise Fiorelli, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1499-1499
Open Access | Times Cited: 48
Electrochemical paper-based antigen sensing platform using plant-derived monoclonal antibody for detecting SARS-CoV-2
Jutamas Jaewjaroenwattana, Waranyoo Phoolcharoen, Ekawat Pasomsub, et al.
Talanta (2022) Vol. 251, pp. 123783-123783
Open Access | Times Cited: 34
Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective
Chunlan Zhuang, Xiaohui Liu, Qi Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 33
An impedimetric biosensor for COVID-19 serology test and modification of sensor performance via dielectrophoresis force
Jie Zeng, Pedro A. Duarte, Yuhao Ma, et al.
Biosensors and Bioelectronics (2022) Vol. 213, pp. 114476-114476
Open Access | Times Cited: 32
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 17
SARS-CoV-2 Infection and Liver Transplant: How Are We Now?
Carlos Gutiérrez García, Antonio Cuadrado, José Ignacio Fortea, et al.
Transplantation Proceedings (2025)
Closed Access
Uncertainty quantification of antibody measurements: Physical principles and implications for standardization
Paul N. Patrone, Lili Wang, Sheng Lin‐Gibson, et al.
Physical review. E (2025) Vol. 111, Iss. 2
Closed Access
Serial Changes of Long COVID Symptoms and Clinical Utility of Serum Antibody Titers for Evaluation of Long COVID
Yasue Sakurada, Naruhiko Sunada, Hiroyuki Honda, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1309-1309
Open Access | Times Cited: 23
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
William A. Werbel, Dorry L. Segev
American Journal of Transplantation (2022) Vol. 22, Iss. 5, pp. 1316-1320
Open Access | Times Cited: 22
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Nora Pisanic, Annukka A.R. Antar, Kate Kruczynski, et al.
Journal of Immunological Methods (2023) Vol. 514, pp. 113440-113440
Open Access | Times Cited: 13
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays
L. P. Müller, Judith Kannenberg, Ronald Biemann, et al.
Journal of Clinical Virology (2022) Vol. 155, pp. 105269-105269
Open Access | Times Cited: 20
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology
Thomas Perkmann, Patrick Mucher, Darlene Ösze, et al.
Journal of Clinical Virology (2022) Vol. 158, pp. 105345-105345
Open Access | Times Cited: 20
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
Poramed Winichakoon, Jiraprapa Wipasa, Kriangkrai Chawansuntati, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study
Sammy Huygens, Tim Preijers, Francis Swaneveld, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 497-509
Open Access | Times Cited: 3
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
Minjeong Nam, Seung Gyu Yun, Sang‐Wook Kim, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 16
Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study
Gaëlle Dauriat, L. Beaumont, Liêm Binh Luong Nguyen, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200502-2200502
Open Access | Times Cited: 16
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage
Christoph Buchta, David Niklas Springer, Jovana Jovanović, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1349-1358
Open Access | Times Cited: 9
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
P Housset, Sabah Kubab, Agathe Pardon, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 3, pp. 783-785
Open Access | Times Cited: 14
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 8
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection
Keon Young Lee, Kyoung‐Ho Song, Kyoung Hwa Lee, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3953-3960
Closed Access | Times Cited: 2
A Paper-Based Multiplexed Serological Test to Monitor Immunity against SARS-COV-2 Using Machine Learning
Merve Eryılmaz, Artem Goncharov, Gyeo‐Re Han, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16819-16831
Open Access | Times Cited: 2
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration
Eleonora Nicolai, Flaminia Tomassetti, Stefano Pignalosa, et al.
COVID (2024) Vol. 4, Iss. 8, pp. 1272-1290
Open Access | Times Cited: 2
Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine
Eman A. Omran, Roaa El Naggar, L. Ezz Elarab, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1340-1340
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top